| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A benign clear cell tumor of the lung that grew gradually over five years
|
|
|
1995
|
13 |
3 |
p. 330-
1 p.
|
artikel
|
| 2 |
A case of lung cancer with choroidal metastasis
|
|
|
1995
|
13 |
3 |
p. 336-
1 p.
|
artikel
|
| 3 |
A case of malignant salivary gland type mixed tumor of the bronchus
|
|
|
1995
|
13 |
3 |
p. 331-
1 p.
|
artikel
|
| 4 |
A case of small intestinal metastasis with an enlarged lymph node detected 7 years after operation of the lung cancer
|
|
|
1995
|
13 |
3 |
p. 340-
1 p.
|
artikel
|
| 5 |
Adjuvant immunotherapy with interleukin 2 and lymphokine-activated killer cells after noncurative resection of primary lung cancer
|
|
|
1995
|
13 |
3 |
p. 344-
1 p.
|
artikel
|
| 6 |
Adoptive immunotherapy in the postoperative treatment of non-small cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 354-
1 p.
|
artikel
|
| 7 |
Adoptive immunotherapy in the treatment of advanced non-small cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 355-
1 p.
|
artikel
|
| 8 |
β-adrenergic mitogenic signal transduction in peripheral lung adenocarcinoma: Implications for individuals with preexisting chronic lung disease
|
|
|
1995
|
13 |
3 |
p. 324-
1 p.
|
artikel
|
| 9 |
A historical perspective of multi-modality treatment for resectable non-small cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 354-
1 p.
|
artikel
|
| 10 |
Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers
|
|
|
1995
|
13 |
3 |
p. 324-
1 p.
|
artikel
|
| 11 |
Alternative daily subcutaneous injections of 4ìg/kg lenograstim in lung cancer case
|
|
|
1995
|
13 |
3 |
p. 346-
1 p.
|
artikel
|
| 12 |
Analysis of patients with resected small peripheral lung cancers 2cm or less in diameter
|
|
|
1995
|
13 |
3 |
p. 337-
1 p.
|
artikel
|
| 13 |
A phase II study of paclitaxel and granulocyte colony-stimulating factor in previously untreated patients with extensive-stage small cell lung cancer: A study of the North Central Cancer Treatment Group
|
|
|
1995
|
13 |
3 |
p. 348-
1 p.
|
artikel
|
| 14 |
A randomised trial of two cisplatin-containing chemotherapy regimens in patients with Stage III-B and IV non-small cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 350-
1 p.
|
artikel
|
| 15 |
Assessment of ‘quality of life’ using a daily diary card in a randomised trial of chemotherapy in small-cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 356-
1 p.
|
artikel
|
| 16 |
Biology of small cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 328-
1 p.
|
artikel
|
| 17 |
Bronchoalveolar lavage fluid level of carcinoembryonic antigen in the diagnosis of peripheral lung cancer
|
|
|
1995
|
13 |
3 |
p. 334-
1 p.
|
artikel
|
| 18 |
Bronchoalveolar lavage in the diagnosis of low-grade, MALT type, B-cell lymphoma in the lung
|
|
|
1995
|
13 |
3 |
p. 334-
1 p.
|
artikel
|
| 19 |
Bronchogenic carcnoma with metastases to the foot: A report of two cases
|
|
|
1995
|
13 |
3 |
p. 340-
1 p.
|
artikel
|
| 20 |
Carboplatin/etoposide combination chemotherapy in the treatment of poor prognosis patients with small cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 346-
1 p.
|
artikel
|
| 21 |
Characterisation of a human small-cell lung cancer cell line resistant to the DNA topoisomerase I-directed drug topotecan
|
|
|
1995
|
13 |
3 |
p. 344-345
2 p.
|
artikel
|
| 22 |
Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: A prospective phase III randomized study of the Southwest Oncology Group
|
|
|
1995
|
13 |
3 |
p. 349-
1 p.
|
artikel
|
| 23 |
Chemotherapy with vincristine/ifosfamide/carboplatin/etoposide in small cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 345-
1 p.
|
artikel
|
| 24 |
Clinical implication of symptoms in patients with non-small cell lung cancer treated with definitive radiation therapy
|
Furuta, Masaya
|
|
1995
|
13 |
3 |
p. 275-283
9 p.
|
artikel
|
| 25 |
Clinical utility of tissue polypeptide antigen determination in lung cancer management
|
|
|
1995
|
13 |
3 |
p. 332-
1 p.
|
artikel
|
| 26 |
Codeletion of p15 and p16 genes in primary non-small cell lung carcinoma
|
|
|
1995
|
13 |
3 |
p. 323-
1 p.
|
artikel
|
| 27 |
Combination chemotherapy with vindesine-ifosfamide-cisplatin (VIP) in locally advanced unresectable stage III and in stage IV non-small cell lung cancer: a phase II trial
|
Vansteenkiste, J.
|
|
1995
|
13 |
3 |
p. 295-303
9 p.
|
artikel
|
| 28 |
Combined modality treatment for stage III non-small cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 353-
1 p.
|
artikel
|
| 29 |
Combined pulmonary and thoracic wall resection for stage III lung cancer
|
|
|
1995
|
13 |
3 |
p. 342-
1 p.
|
artikel
|
| 30 |
Comparison of serum proGRP and NSE levels in patients with small cell carcinoma
|
|
|
1995
|
13 |
3 |
p. 337-
1 p.
|
artikel
|
| 31 |
Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA(N2) and IIIB non-small-cell lung cancer: Mature results of Southwest Oncology Group Phase II Study 8805
|
|
|
1995
|
13 |
3 |
p. 352-
1 p.
|
artikel
|
| 32 |
Concurrent paclitaxel and thoracic radiation for advanced non-small cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 353-
1 p.
|
artikel
|
| 33 |
Congenital cystic adenomatoid malformation of the lung in adults associated with bronchioloalveolar carcinoma
|
|
|
1995
|
13 |
3 |
p. 337-
1 p.
|
artikel
|
| 34 |
Cross-resistance to antineoplastic agents in a human small cell lung cancer subline resistant to okadaic acid
|
|
|
1995
|
13 |
3 |
p. 345-
1 p.
|
artikel
|
| 35 |
Cutaneous sarcoid granulomas with oat cell carcinoma of the lung
|
|
|
1995
|
13 |
3 |
p. 340-
1 p.
|
artikel
|
| 36 |
Cyfra 21-1 as a biologic marker of non-small cell lung cancer: Evaluation of sensitivity, specificity, and prognostic role
|
|
|
1995
|
13 |
3 |
p. 338-
1 p.
|
artikel
|
| 37 |
Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings
|
|
|
1995
|
13 |
3 |
p. 332-333
2 p.
|
artikel
|
| 38 |
Detection of K-ras mutations in non-small cell lung carcinoma
|
|
|
1995
|
13 |
3 |
p. 330-
1 p.
|
artikel
|
| 39 |
Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis
|
|
|
1995
|
13 |
3 |
p. 337-338
2 p.
|
artikel
|
| 40 |
Development of quality of life (QOL) questionnaire for use of lung cancer patients in palliative therapy — Study of validity and reliability no. 1
|
|
|
1995
|
13 |
3 |
p. 339-
1 p.
|
artikel
|
| 41 |
Development of quality of life (QOL) questionnaire for use of lung cancer patients in palliative therapy — Study of validity and reliability no. 2, the effects of chemotherapeutics in QOL
|
|
|
1995
|
13 |
3 |
p. 356-
1 p.
|
artikel
|
| 42 |
Diagnostic value of serum CYFRA 21-1 in lung cancer
|
|
|
1995
|
13 |
3 |
p. 334-335
2 p.
|
artikel
|
| 43 |
Differences in initial treatment patterns and outcomes of lung cancer in the elderly
|
Smith, Thomas J.
|
|
1995
|
13 |
3 |
p. 235-252
18 p.
|
artikel
|
| 44 |
Discriminant analysis on small cell lung cancer and non-small cell lung cancer by means of NSE and CYFRA-21.1
|
|
|
1995
|
13 |
3 |
p. 333-
1 p.
|
artikel
|
| 45 |
Does knowledge guide practice? Another look at the management of non- small-cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 355-356
2 p.
|
artikel
|
| 46 |
Dose-finding study of paclitaxel (Taxol) plus cisplatin in patients with non-small cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 347-
1 p.
|
artikel
|
| 47 |
Effect of anti-CD3 antibody (OKT3) on the cytotoxicity of LAK cells induced from regional lymph node lymphocytes in lung cancer patients
|
|
|
1995
|
13 |
3 |
p. 327-
1 p.
|
artikel
|
| 48 |
Elevated expression of Unph, a proto-oncogene at 3p21.3, in human lung tumors
|
|
|
1995
|
13 |
3 |
p. 329-
1 p.
|
artikel
|
| 49 |
Enzyme-linked immunosorbent assay of pro-gastrin-releasing peptide for small cell lung cancer patients in comparison with neuron-specific enolase measurement
|
|
|
1995
|
13 |
3 |
p. 335-
1 p.
|
artikel
|
| 50 |
Etoposide phosphate or etoposide with cisplatin in the treatment of small cell lung cancer: Randomized Phase II trial
|
|
|
1995
|
13 |
3 |
p. 346-347
2 p.
|
artikel
|
| 51 |
Etoposide (VP-16) and cisplatin at maximum tolerated dose in non-small cell lung carcinoma: a Cancer and Leukemia Group B study
|
Muscato, Joseph J.
|
|
1995
|
13 |
3 |
p. 285-294
10 p.
|
artikel
|
| 52 |
Evaluation of hilar 67Ga-citrate uptake in bronchogenic carcinoma
|
|
|
1995
|
13 |
3 |
p. 340-
1 p.
|
artikel
|
| 53 |
Evaluation of prognosis based on the previous annual checkup miniature roentgenograms of lung cancer cases detected by chest radiologic mass screening
|
|
|
1995
|
13 |
3 |
p. 336-
1 p.
|
artikel
|
| 54 |
Evaluation of the treatment of 62 patients with advanced cancer by using lymphokine-activated killer cells plus interleukin-2
|
|
|
1995
|
13 |
3 |
p. 345-
1 p.
|
artikel
|
| 55 |
Evaluation of Tl-201 SPECT for monitoring the treatment of pulmonary and mediastinal tumors
|
|
|
1995
|
13 |
3 |
p. 340-
1 p.
|
artikel
|
| 56 |
Experiences in tracheobronchoplasty
|
|
|
1995
|
13 |
3 |
p. 341-
1 p.
|
artikel
|
| 57 |
Expression of p53 oncoprotein in non-small-cell lung cancer: A favorable prognostic factor
|
|
|
1995
|
13 |
3 |
p. 332-
1 p.
|
artikel
|
| 58 |
Expression of several biologic markers as prognostic markers in non-small cell lung cancers
|
|
|
1995
|
13 |
3 |
p. 334-
1 p.
|
artikel
|
| 59 |
Expression of the BCL-2 protein in normal and dysplastic bronchial epithelium and in lung carcinomas
|
|
|
1995
|
13 |
3 |
p. 331-
1 p.
|
artikel
|
| 60 |
False-positive interpretations of carcinoma in exfoliative respiratory cytology: Report of two cases and a review of underlying disorders
|
|
|
1995
|
13 |
3 |
p. 332-
1 p.
|
artikel
|
| 61 |
Fiberobronchoscopic findings in 246 cases of central type of lung cancer
|
|
|
1995
|
13 |
3 |
p. 335-
1 p.
|
artikel
|
| 62 |
Future directions in non-small cell lung cancer. A personal view
|
|
|
1995
|
13 |
3 |
p. 355-
1 p.
|
artikel
|
| 63 |
Glutathione S transferase Pi is a powerful indicator in chemotherapy of human lung squamous-cell carcinoma
|
|
|
1995
|
13 |
3 |
p. 343-
1 p.
|
artikel
|
| 64 |
High-dose chemotherapy combined with peripheral blood stem cell transplantation for two cases with small-cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 346-
1 p.
|
artikel
|
| 65 |
High dose intensification chemotherapy with autologous bone marrow transplantation in small cell lung cancer. A pilot study
|
|
|
1995
|
13 |
3 |
p. 348-
1 p.
|
artikel
|
| 66 |
High expression of adhesion molecules/activation markers with little interleukin-2, interferon gamma, and tumor necrosis factor β gene activation in fresh tumor-infiltrating lymphocyte from lung adenocarcinoma
|
|
|
1995
|
13 |
3 |
p. 333-334
2 p.
|
artikel
|
| 67 |
Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers
|
|
|
1995
|
13 |
3 |
p. 327-328
2 p.
|
artikel
|
| 68 |
IASLC calendar
|
|
|
1995
|
13 |
3 |
p. 319-321
3 p.
|
artikel
|
| 69 |
Ifosfamide/carboplatin/etoposide chemotherapy in patients with metastatic non-small cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 345-
1 p.
|
artikel
|
| 70 |
Ifosfamide plus high-dose cisplatin in patients with non-small cell lung cancer previously treated with chemotherapy
|
|
|
1995
|
13 |
3 |
p. 344-
1 p.
|
artikel
|
| 71 |
Immunohistochemical study of adhesion molecules expressed on lung carcinoma cells: Its association with lymph node metastasis
|
|
|
1995
|
13 |
3 |
p. 331-
1 p.
|
artikel
|
| 72 |
Incidence of latent infection of Epstein-Barr virus in lung cancers — An analysis of EBER1 expression in lung cancers by in situ hybridization
|
|
|
1995
|
13 |
3 |
p. 327-
1 p.
|
artikel
|
| 73 |
Increased occurrence of cancer of the respiratory tract following exposure to tar — A retrospective view
|
|
|
1995
|
13 |
3 |
p. 324-
1 p.
|
artikel
|
| 74 |
Increasing lung cancer mortality rates in the elderly: A manifestation of differential survival
|
|
|
1995
|
13 |
3 |
p. 326-
1 p.
|
artikel
|
| 75 |
Inhibitory effect of cold stress on lung tumours induced by 7,12-dimethylbenz[a]anthracene in mice
|
|
|
1995
|
13 |
3 |
p. 325-
1 p.
|
artikel
|
| 76 |
Insulin-like growth factor-I is an autocrine regulator for the brain metastatic variant of a human non-small cell lung cell line
|
|
|
1995
|
13 |
3 |
p. 326-
1 p.
|
artikel
|
| 77 |
Integration of vinorelbine into chemotherapy strategies for non-small-cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 348-
1 p.
|
artikel
|
| 78 |
Intensive follow-up after curative resection for lung cancer
|
|
|
1995
|
13 |
3 |
p. 341-
1 p.
|
artikel
|
| 79 |
Invasion of the thoracic wall in primary lung cancer
|
|
|
1995
|
13 |
3 |
p. 338-339
2 p.
|
artikel
|
| 80 |
Localized adenocarcinoma of the lung: Oncogene expression of erbB-2 and p53 in 150 patients
|
|
|
1995
|
13 |
3 |
p. 331-332
2 p.
|
artikel
|
| 81 |
Long term results of a Phase I II study of aggressive chemotherapy and sequential upper and lower hemibody radiation for patients with extensive stage small cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 350-351
2 p.
|
artikel
|
| 82 |
Long-term survival after lung resection for cancer in the aged
|
|
|
1995
|
13 |
3 |
p. 341-
1 p.
|
artikel
|
| 83 |
Long-term survival of surgical cases of lung cancer
|
Wada, Hiromi
|
|
1995
|
13 |
3 |
p. 269-274
6 p.
|
artikel
|
| 84 |
Loss of heterozygosity at 9p23 defines a novel locus in non-small cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 326-
1 p.
|
artikel
|
| 85 |
Low dose rate versus high dose rate intraluminal brachytherapy for malignant endobronchial tumors
|
|
|
1995
|
13 |
3 |
p. 351-
1 p.
|
artikel
|
| 86 |
Lung cancer and tobacco smoking
|
|
|
1995
|
13 |
3 |
p. 323-
1 p.
|
artikel
|
| 87 |
Lung cancer mortality rate falling among men, rising among women
|
|
|
1995
|
13 |
3 |
p. 325-
1 p.
|
artikel
|
| 88 |
Lung scanning and exercise testing for the prediction of postoperative performance in lung resection candidates at increased risk for complications
|
|
|
1995
|
13 |
3 |
p. 340-341
2 p.
|
artikel
|
| 89 |
MRP gene overexpression in a human doxorubicin-resistant SCLC cell line: Alterations in cellular pharmacokinetics and in pattern of cross-resistance
|
|
|
1995
|
13 |
3 |
p. 347-348
2 p.
|
artikel
|
| 90 |
Mutations in the p53 gene in lung cancer are associated with cigarette smoking and asbestos exposure
|
|
|
1995
|
13 |
3 |
p. 328-
1 p.
|
artikel
|
| 91 |
Neoadjuvant chemotherapy of stage III-A and B lung carcinoma using the PACCO regimen
|
|
|
1995
|
13 |
3 |
p. 354-
1 p.
|
artikel
|
| 92 |
Neoadjuvant (induction) treatment for non-small cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 353-354
2 p.
|
artikel
|
| 93 |
New chemotherapy agents in the treatment of advanced non-small cell lung cancer: An update including data from the Seventh World Conference on Lung Cancer
|
|
|
1995
|
13 |
3 |
p. 347-
1 p.
|
artikel
|
| 94 |
New drugs for treating small cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 346-
1 p.
|
artikel
|
| 95 |
New treatment agents for advanced small cell and non-small cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 349-
1 p.
|
artikel
|
| 96 |
Non-small-cell lung cancer with multiple paraneoplastic syndromes
|
|
|
1995
|
13 |
3 |
p. 333-
1 p.
|
artikel
|
| 97 |
Non-uniform dose/time fractionated radiation therapy and chemotherapy for non-small cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 352-
1 p.
|
artikel
|
| 98 |
No occurrence of DNA polymerase β gene mutation in human lung carcinoma cell lines with K-ras, p53, or Rb gene alterations
|
|
|
1995
|
13 |
3 |
p. 326-
1 p.
|
artikel
|
| 99 |
Nuclear DNA and nuclear protein content of tumor cell in adenocarcinoma of the lung
|
|
|
1995
|
13 |
3 |
p. 330-
1 p.
|
artikel
|
| 100 |
OK-432 accelerates recovery from myelosuppression induced by combination chemotherapy for advanced lung cancer
|
|
|
1995
|
13 |
3 |
p. 345-
1 p.
|
artikel
|
| 101 |
Ongoing randomised trials in lung cancer
|
|
|
1995
|
13 |
3 |
p. 317-
1 p.
|
artikel
|
| 102 |
Oral therapy for small cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 346-
1 p.
|
artikel
|
| 103 |
Orosomucoid: Prealbumine ratio in lung cancer
|
|
|
1995
|
13 |
3 |
p. 335-
1 p.
|
artikel
|
| 104 |
Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: A phase II toxicity, response, and survival analysis
|
|
|
1995
|
13 |
3 |
p. 350-
1 p.
|
artikel
|
| 105 |
Paclitaxel and carboplatin in the treatment of advanced non-small cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 349-
1 p.
|
artikel
|
| 106 |
Paclitaxel as a radiation sensitizer in non-small cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 351-
1 p.
|
artikel
|
| 107 |
P53 antibodies in the sera of lung cancer patients: Comparison with p53 mutation in the tumour tissue
|
|
|
1995
|
13 |
3 |
p. 338-
1 p.
|
artikel
|
| 108 |
Paraneoplastic limbic encephalitis
|
|
|
1995
|
13 |
3 |
p. 339-
1 p.
|
artikel
|
| 109 |
Parathyroid hormone-related protein antigen localization distinguishes between mesothelioma and adenocarcinoma of the lung
|
|
|
1995
|
13 |
3 |
p. 331-
1 p.
|
artikel
|
| 110 |
Phase I–II and pharmacokinetic study of a new fotemustine schedule in advanced non-small cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 344-
1 p.
|
artikel
|
| 111 |
Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: An Eastern Cooperative Oncology Group pilot study
|
|
|
1995
|
13 |
3 |
p. 349-350
2 p.
|
artikel
|
| 112 |
Phase II study with paclitaxel for the treatment of advanced inoperable non-small cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 347-
1 p.
|
artikel
|
| 113 |
Pilot study of irinotecan in refractory small cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 348-
1 p.
|
artikel
|
| 114 |
Point mutation of the somatostatin receptor 2 gene in the human small cell lung cancer cell line COR-L103
|
|
|
1995
|
13 |
3 |
p. 327-
1 p.
|
artikel
|
| 115 |
Polymorphisms of human Ah receptor gene are not involved in lung cancer
|
|
|
1995
|
13 |
3 |
p. 329-
1 p.
|
artikel
|
| 116 |
Poorly differentiated non-small cell carcinoma of the lung in acquired immunodeficiency syndrome
|
|
|
1995
|
13 |
3 |
p. 332-
1 p.
|
artikel
|
| 117 |
Predicting postoperative pulmonary function in patients undergoing lung resection
|
|
|
1995
|
13 |
3 |
p. 342-
1 p.
|
artikel
|
| 118 |
Pre-treatment prognostic factors in patients with Stage III non-small cell lung cancer treated with hyperfractionated radiation therapy with or without concurrent chemotherapy
|
|
|
1995
|
13 |
3 |
p. 354-355
2 p.
|
artikel
|
| 119 |
Primary lymphoepithelioma-like carcinoma of the lung: A clinicopathologic study of 11 cases
|
|
|
1995
|
13 |
3 |
p. 330-331
2 p.
|
artikel
|
| 120 |
Prognosis in primary, resected non-small cell carcinoma cases with intrapulmonary metastasis
|
|
|
1995
|
13 |
3 |
p. 342-
1 p.
|
artikel
|
| 121 |
Prognostic significance of peritumoural blood and lymphatic vessel invasion by tumour cells in T4 non-small cell lung cancer following induction therapy
|
|
|
1995
|
13 |
3 |
p. 339-
1 p.
|
artikel
|
| 122 |
Proliferating cell nuclear antigen may be superior to argyrophilic nucleolar organizer regions in predicting shortened survival of patients with non-small cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 339-
1 p.
|
artikel
|
| 123 |
Prophylactic cranial irradiation in small cell lung cancer — an update
|
|
|
1995
|
13 |
3 |
p. 351-
1 p.
|
artikel
|
| 124 |
Pulmonary expression of glutathione S-transferase M3 in lung cancer patients: Association with GSTM1 polymorphism, smoking, and asbestos exposure
|
|
|
1995
|
13 |
3 |
p. 324-
1 p.
|
artikel
|
| 125 |
Radiosurgical treatment of lung cancer
|
|
|
1995
|
13 |
3 |
p. 353-
1 p.
|
artikel
|
| 126 |
Radiotherapy alone for non-small cell lung carcinoma. Five-year disease-free survival and patterns of failure
|
|
|
1995
|
13 |
3 |
p. 348-
1 p.
|
artikel
|
| 127 |
Radiotherapy and chemotherapy for inoperable non-small cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 346-
1 p.
|
artikel
|
| 128 |
Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in Stages IIIa and IIIb nonsmall cell lung cancer: A meta-analysis
|
|
|
1995
|
13 |
3 |
p. 352-
1 p.
|
artikel
|
| 129 |
Registration of lung cancer in Scotland: An assessment of data accuracy based on review of medical records
|
|
|
1995
|
13 |
3 |
p. 325-
1 p.
|
artikel
|
| 130 |
Relation between exposure to environmental tobacco smoke and lung cancer in lifetime nonsmokers
|
|
|
1995
|
13 |
3 |
p. 325-
1 p.
|
artikel
|
| 131 |
Relationship between tumor response and the ratio of nucleotide triphosphates to inorganic phosphate in small cell lung cancer xenografts
|
|
|
1995
|
13 |
3 |
p. 329-
1 p.
|
artikel
|
| 132 |
Report of a prospective trial — Split course versus conventional radiotherapy in the treatment of non small cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 351-
1 p.
|
artikel
|
| 133 |
Resection of lung cancer complicated by pleural empyema
|
|
|
1995
|
13 |
3 |
p. 341-
1 p.
|
artikel
|
| 134 |
Results of a limited resection for compromised or poor-risk patients with clinical stage I non-small cell carcinoma of the lung
|
|
|
1995
|
13 |
3 |
p. 342-343
2 p.
|
artikel
|
| 135 |
Retinoic acid modulates epidermal growth factor receptor expression in human lung epithelial cancer cells
|
|
|
1995
|
13 |
3 |
p. 326-
1 p.
|
artikel
|
| 136 |
Retinoid chemoprevention of aerodigestive cancer: From basic research to the clinic
|
|
|
1995
|
13 |
3 |
p. 323-
1 p.
|
artikel
|
| 137 |
Role of cytokines in distribution and differentiation of dendritic cell/Langerhans' cell lineage in human primary carcinomas of the lung
|
|
|
1995
|
13 |
3 |
p. 329-330
2 p.
|
artikel
|
| 138 |
Role of sodium pump systems to determine sensitivity to mitomycin C in non-small cell lung cancer cell lines
|
|
|
1995
|
13 |
3 |
p. 343-
1 p.
|
artikel
|
| 139 |
Schedule dependency of 21-day oral versus 3-day intravenous etoposide in combination with intravenous cisplatin in extensive-stage small-cell lung cancer: A randomized phase III study of the cancer and leukemia group B
|
|
|
1995
|
13 |
3 |
p. 343-344
2 p.
|
artikel
|
| 140 |
Scheduling of chemotherapy and radiotherapy in locally advanced non-small cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 353-
1 p.
|
artikel
|
| 141 |
Serum level and tissue expression of c-erbB-2 protein in lung adenocarcinoma
|
|
|
1995
|
13 |
3 |
p. 338-
1 p.
|
artikel
|
| 142 |
Serum p53 antibodies as early markers of lung cancer
|
|
|
1995
|
13 |
3 |
p. 339-
1 p.
|
artikel
|
| 143 |
Single-agent chemotherapy versus combination chemotherapy in advanced non-small cell lung cancer: A quality and meta-analysis study
|
|
|
1995
|
13 |
3 |
p. 344-
1 p.
|
artikel
|
| 144 |
Smal peripheral lung carcinoma evaluated with incremental dynamic CT: Radiologic-pathologic correlation
|
|
|
1995
|
13 |
3 |
p. 335-
1 p.
|
artikel
|
| 145 |
Striking changes in smoking behaviour and lung cancer incidence by histological type in south-east Netherlands, 1960–1991
|
|
|
1995
|
13 |
3 |
p. 325-326
2 p.
|
artikel
|
| 146 |
Subacute encephalopathic toxicity of cisplatin
|
Verschraegen, Claire
|
|
1995
|
13 |
3 |
p. 305-309
5 p.
|
artikel
|
| 147 |
Successful xenotransplantation of human lung cancer correlates with the metastatic phenotype
|
|
|
1995
|
13 |
3 |
p. 327-
1 p.
|
artikel
|
| 148 |
Surgical treatment for acute pulmonary thromboembolism occurring 9 months after an operation for lung cancer
|
|
|
1995
|
13 |
3 |
p. 341-
1 p.
|
artikel
|
| 149 |
Surgical treatment of pulmonary carcinoma in individuals over 80 years of age
|
|
|
1995
|
13 |
3 |
p. 343-
1 p.
|
artikel
|
| 150 |
Surgical treatment of small cell carcinoma of the lung: Advantage of preoperative chemotherapy
|
|
|
1995
|
13 |
3 |
p. 352-353
2 p.
|
artikel
|
| 151 |
Survival of stage I lung cancer patients with previous or subsequent primary malignant neoplasms
|
|
|
1995
|
13 |
3 |
p. 335-336
2 p.
|
artikel
|
| 152 |
Survival predictors in advanced non-small cell lung cancer
|
Hespanhol, V.
|
|
1995
|
13 |
3 |
p. 253-267
15 p.
|
artikel
|
| 153 |
The clinical evaluation for detecting metastatic lung cancer: A meta- analysis
|
|
|
1995
|
13 |
3 |
p. 336-
1 p.
|
artikel
|
| 154 |
The 3D-CT angiography and MPR images of lung cancer cases
|
|
|
1995
|
13 |
3 |
p. 336-
1 p.
|
artikel
|
| 155 |
The efficacy of megavoltage imaging in the radical radiotherapy of non-small cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 351-352
2 p.
|
artikel
|
| 156 |
The evolution of Radiation Therapy Oncology Group (RTOG) protocols for nonsmall cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 350-
1 p.
|
artikel
|
| 157 |
The medical treatment of lung cancer
|
|
|
1995
|
13 |
3 |
p. 355-
1 p.
|
artikel
|
| 158 |
The role of dietary factors in lung cancer
|
|
|
1995
|
13 |
3 |
p. 323-
1 p.
|
artikel
|
| 159 |
The value of PE-10, a monoclonal antibody against pulmonary surfactant, in distinguishing primary and metastatic lung tumours
|
|
|
1995
|
13 |
3 |
p. 330-
1 p.
|
artikel
|
| 160 |
Thin-section CT-pathologic correlation in pulmonary adenocarcinoma
|
|
|
1995
|
13 |
3 |
p. 336-
1 p.
|
artikel
|
| 161 |
Tumor progression by lung cancers growing in hosts of different immunocompetence
|
|
|
1995
|
13 |
3 |
p. 328-329
2 p.
|
artikel
|
| 162 |
Two-stage bronchoplasty for synchronous contralateral lung cancers
|
|
|
1995
|
13 |
3 |
p. 341-
1 p.
|
artikel
|
| 163 |
Ultrasonic assessment of hemidiaphragmatic movement: An indirect method of evaluating mediastinal invasion in non-small cell lung cancer
|
|
|
1995
|
13 |
3 |
p. 333-
1 p.
|
artikel
|
| 164 |
Variation of p53 mutational spectra between carcinoma of the upper and lower respiratory tract
|
|
|
1995
|
13 |
3 |
p. 328-
1 p.
|
artikel
|
| 165 |
Well-differentiated fetal adenocarcinoma of lung
|
Fujino, Shozo
|
|
1995
|
13 |
3 |
p. 311-316
6 p.
|
artikel
|
Tijdschrift beschrijving